Validation of IKKA Score to unificate the evaluation of individual risk by a SARS-CoV-2 infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025536

Enrollment

1379

Registered

2021-06-15

Start date

2021-06-22

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

INFEKTION

Interventions

Group 1: Validation of the IKKA score on patients and clinic employees of Kliniken Nordoberpfalz AG (Weiden, Tirschenreuth) with confirmed SARS-CoV-2 infection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Persons with a confirmed SARS-CoV-2 infection with hospitalisation in Klinikum Weiden/Tirschenreuth or employees of the aforementioned clinic with a confirmed SARS-CoV-2 infection between 01/2020 and 12/2020

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Using the issued questionnaires, the progression of the SARS-CoV-2 infection as well as the prior conditions of the corresponding person is retrospectively collected. Furthermore, the IKKA score is calculated in order to clarify whether the computation of an IKKA score is sufficient to identify persons with a severe progression of COVID-19.	—

Secondary

Measure	Time frame
Using the issued questionnaires, the prior conditions of the corresponding persons is retrospectively collected. With the aid of the collected data, potential autonomous risk factors should be investigated for a severe progression of a COVID-19 disease.	—

Countries

Germany

Contacts

Public ContactAnna Wolfschmidt

Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin (IPASUM)

anna.wolfschmidt@fau.de091318526114

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026